Cytotoxic Reviews

In this topical collection (28 articles)

Page is not a valid page number. Please enter a number between 1 and 2 of 2

1. Introduction

   Cytotoxic drugs: past, present and future

   Herbie Newell, Edward Sausville Page 1

   Download PDF (351KB) View Article

2. 

   Review Article

   DNA topoisomerase-targeting chemotherapeutics: what’s new?

   Selma M. Cuya, Mary-Ann Bjornsti… Pages 1-14

3. 

   Review Article

   Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments

   Jessica J. Hopkins, Michael B. Sawyer Pages 1-29

4. 

   Review Article

   The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancer

   Larry H. Matherly, Zhanjun Hou, Aleem Gangjee Pages 1-15

5. Review Article

   Pharmacokinetics and pharmacogenetics of Gemcitabine as a mainstay in adult and pediatric oncology: an EORTC-PAMM perspective

   Joseph Ciccolini, Cindy Serdjebi… Pages 1-12

   Download PDF (662KB) View Article

6. 

   Review Article

   Incidence of interstitial pneumonitis in breast cancer patients treated with pegylated liposomal doxorubicin

   Liwei Meng, Liming Huang, Yingchun Xu, Wei Zhang Pages 3-7

7. Introduction

   Contemporary reviews on cancer treatment

   Godefridus J. Peters, Eric Raymond Pages 3-4

   Download PDF (337KB) View Article

8. 

   Review Article

   Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy

   Paola Perego, Jacques Robert Pages 5-18

9. 

   Review Article

   Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations

   Chukwunonso K. Nwabufo Pages 89-105

10. 

    Review Article

    Identifying novel therapeutic agents using xenograft models of pediatric cancer

    Raushan T. Kurmasheva, Peter J. Houghton Pages 221-232

11. 

    Review Article

    Treatment regimens of classical and newer taxanes

    Markus Joerger Pages 221-233

12. Review Article

    Positioning of proteasome inhibitors in therapy of solid malignancies

    Margot S. F. Roeten, Jacqueline Cloos… Pages 227-243

    Download PDF (1712KB) View Article

13. 

    Review Article

    Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cells

    Rachel E. Nicoletto, Clyde M. Ofner III Pages 285-311

14. 

    Review Article

    Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics

    Salvador Fudio, Alvaro Sellers, Laura Pérez Ramos… Pages 285-299

15. 

    Review Article

    Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group

    Paola Perego, Georg Hempel, Stig Linder… Pages 427-441

16. 

    Review Article

    Asparaginase pharmacology: challenges still to be faced

    Claudia Lanvers-Kaminsky Pages 439-450

17. Review Article

    Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs

    Roger M. Phillips Pages 441-457

    Download PDF (803KB) View Article

18. 

    Review Article

    Therapeutic drug monitoring of 5-fluorouracil

    James J. Lee, Jan H. Beumer, Edward Chu Pages 447-464

19. 

    Review Article

    Anti-drug antibodies in the current management of cancer

    Miguel Borregón, Katherine Martínez, Alba Ramos… Pages 577-584

20. 

    Review Article

    The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy

    Martina Ahlmann, Georg Hempel Pages 661-671

Page is not a valid page number. Please enter a number between 1 and 2 of 2